CJC-1295 with DAC: What It Is and How It's Used in the Philippines

Quick read: CJC-1295 with DAC is a long-acting growth hormone releasing hormone (GHRH) analog that elevates baseline GH and IGF-1 levels for 7-10 days per injection. Dosed at 100mcg 1-2x weekly, it's used for recovery, body recomposition, anti-aging, and sleep improvement. In PH, it's popular for convenience (less frequent pinning than daily peptides) and among users 35+ looking to restore GH levels.

What it is

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone releasing hormone (GHRH), the natural peptide that signals the pituitary gland to release growth hormone (GH).

The key feature is the DAC modification: a chemical linker that allows CJC-1295 to bind to albumin in the blood. This extends its half-life to roughly 8 days, compared to 30 minutes for natural GHRH. The result is sustained GH elevation over a week rather than a short pulse.

The mechanism: CJC-1295 binds to GHRH receptors on pituitary somatotrophs (GH-secreting cells) and triggers GH release. Unlike GHRP-class peptides (ipamorelin, GHRP-2/6) which mimic ghrelin, CJC-1295 works through the GHRH pathway. The two mechanisms are complementary, which is why CJC-1295 is often stacked with ipamorelin.

GH itself has a short half-life (minutes), but it triggers the liver to produce IGF-1 (insulin-like growth factor 1), which has a longer half-life and mediates many of GH's anabolic and metabolic effects.

Research on CJC-1295 with DAC comes primarily from a 2006 study by Teichman et al., which showed sustained elevation of GH and IGF-1 levels for up to 14 days after a single injection. The compound has been used in the research and wellness communities for years, though it's not FDA-approved for any medical indication.

In the PH peptide landscape, CJC-1295 with DAC is used for recovery, anti-aging, fat loss, and sleep improvement. It's popular among users 35+ who want to restore declining GH levels without daily injections.

What it's used for

Primary use: Body recomposition and anti-aging. CJC-1295 with DAC elevates GH and IGF-1, which supports muscle retention during caloric deficits, improves fat oxidation (especially visceral fat), and enhances recovery. It's often run during fat loss phases or by older users (40+) looking to restore youthful GH levels.

Secondary use: Recovery and sleep quality. Elevated GH improves sleep depth (especially slow-wave sleep) and accelerates recovery from training. Users report feeling more rested and recovering faster between sessions.

Tertiary use: Skin, hair, and connective tissue quality. GH and IGF-1 support collagen synthesis, which improves skin elasticity, hair thickness, and tendon/ligament health.

Realistic expectations: Users running CJC-1295 with DAC for 8-12 weeks typically report improved body composition (muscle retention during cuts, slight fat loss), better sleep, and faster recovery. The effects are subtle and cumulative, not dramatic like exogenous GH.

CJC-1295 with DAC is not a mass-building compound. It's a support tool for recovery and body recomposition, not a primary muscle-building intervention.

Typical protocols

Standard protocol:

• Dose: 100mcg subcutaneous, 1-2x weekly
• Timing: Before bed (to align with natural GH pulse)
• Duration: 8-12 weeks, then cycle off for 4-8 weeks

Conservative protocol (older users or first-time users):

• Dose: 100mcg subcutaneous, once weekly
• Duration: 8 weeks, then reassess based on bloodwork (IGF-1 levels)

Aggressive protocol (advanced users):

• Dose: 200mcg subcutaneous, 1-2x weekly
• Duration: 8-12 weeks
• Note: Higher doses increase side effect risk (numbness, water retention)

Timing: Most users pin before bed to align with the body's natural nocturnal GH pulse, though the 8-day half-life means timing is less critical than with short-acting peptides.

Pin location: Subcutaneous, typically abdomen or thigh.

Reconstitution: CJC-1295 with DAC typically comes as 2mg lyophilized powder. A common reconstitution is 2mg + 2mL bacteriostatic water = 1mg/mL. For a 100mcg dose, that's 0.1mL (10 units on an insulin syringe).

Cycling: Most users run CJC-1295 with DAC for 8-12 weeks, then cycle off for 4-8 weeks to allow the pituitary to normalize and prevent desensitization.

What users typically report

Week 1-2: Most users notice improved sleep quality within the first week. Sleep feels deeper, more restorative. Some users report vivid dreams. Recovery between training sessions may improve slightly.

Week 3-4: Body composition changes start to become noticeable. Slight fat loss (especially around the midsection), improved muscle fullness. Strength may improve slightly. Skin quality and hair thickness may improve.

Week 5-8: Continued body composition improvement. Users in a caloric deficit report better muscle retention than expected. Users at maintenance calories report slow recomposition (fat loss + muscle gain simultaneously).

Week 9-12: The effects plateau. Most of the benefit happens in the first 6-8 weeks.

Variance: Response is individual and age-dependent. Older users (40+) with naturally declining GH levels tend to feel more dramatic improvement than younger users (20s-30s) who already have healthy GH production.

From PH community logs, CJC-1295 with DAC is most effective for users 35+ and for people running it during fat loss phases to preserve muscle. Users expecting rapid muscle gain are usually disappointed.

Common side effects

Numbness and tingling (10-20%): Especially in the hands and fingers (carpal tunnel-like symptoms). This is related to water retention and elevated IGF-1. Usually mild and resolves after stopping or reducing dose.

Water retention (10-15%): Mild bloating or puffiness, especially in the face and hands. More common at higher doses.

Elevated IGF-1 (expected effect): CJC-1295 with DAC raises IGF-1 levels. Excessively high IGF-1 (>400-500 ng/mL) long-term may carry health risks (insulin resistance, organ growth concerns), though this is speculative.

Injection site reactions (5%): Redness, swelling, or itching at the injection site.

Headache (5%): Occasionally reported during the first few pins.

Increased hunger (5-10%): Some users report feeling hungrier, likely due to elevated GH and ghrelin signaling.

Serious side effects are not documented at typical doses. CJC-1295 with DAC doesnt cause the joint pain or organ growth seen with exogenous GH at supraphysiological doses.

One theoretical concern: Elevated GH and IGF-1 could theoretically promote tumor growth if cancer is present. For this reason, CJC-1295 with DAC is contraindicated in people with active cancer or a history of cancer.

Side effect management

Numbness/tingling: Reduce dose to 100mcg once weekly. Ensure adequate potassium and magnesium intake (water retention can compress nerves). If persistent, stop and allow IGF-1 to return to baseline.

Water retention: Reduce sodium intake. Increase water consumption (counterintuitive but helps flush excess sodium). Consider a mild diuretic (dandelion root tea, low-dose hydrochlorothiazide if prescribed). If severe, reduce dose.

Elevated IGF-1: Check IGF-1 levels via bloodwork at week 4-6. If IGF-1 is >400 ng/mL, consider reducing dose or frequency. Long-term IGF-1 >500 ng/mL is generally considered undesirable.

Injection site reactions: Rotate sites. Use a fresh needle. Inject slowly.

Increased hunger: Not harmful, but may interfere with fat loss goals. Track calories more carefully or adjust meal timing.

Who this compound is for

CJC-1295 with DAC is for people looking to improve body composition, recovery, and sleep without daily injections. The ideal user is:

• Someone 35+ with declining GH levels who wants to restore more youthful recovery and body composition
• Someone running a fat loss protocol who wants to preserve muscle mass
• Someone training hard 4-6x weekly who needs better recovery support
• Someone who values convenience (1-2 pins weekly vs daily)

It's especially relevant in the PH corporate demographic (BGC/Makati office workers, 35-55) who have limited time to manage complex protocols and want a simple once-weekly intervention.

Realistic outcome: A 45-year-old running CJC-1295 with DAC for 12 weeks while training 4x weekly and eating at maintenance can expect slight fat loss, improved muscle fullness, better sleep, and faster recovery. They wont look dramatically different, but they'll feel better and perform better.

Who this compound is NOT for

CJC-1295 with DAC is not a muscle-building compound for young, healthy users. If you're 25 with normal GH production, CJC-1295 with DAC will provide minimal benefit.

It's also not appropriate for people looking for rapid fat loss. The fat loss effect is subtle and takes weeks to months.

Active cancer or history of cancer: CJC-1295 with DAC elevates GH and IGF-1, which could theoretically promote tumor growth. Contraindicated.

Type 1 or poorly controlled type 2 diabetes: GH can worsen insulin resistance. Use with caution and monitor blood glucose closely.

Pregnancy and breastfeeding: No human safety data, so it's best to avoid.

People unwilling to check bloodwork: IGF-1 should be monitored to ensure levels dont climb excessively. If you're not willing to get bloodwork, dont run CJC-1295 with DAC.

PH-specific considerations

Convenience for irregular pinning schedules: The 8-day half-life makes CJC-1295 with DAC forgiving. If you miss a pin by a day or two, it doesnt matter much. This is appealing for busy PH professionals who travel frequently or have inconsistent schedules.

IGF-1 monitoring at PH labs: IGF-1 testing is available at major labs in Manila (Hi-Precision, MedGrocer, clinical labs in Makati/BGC) for 1500-2500 PHP. Baseline IGF-1 before starting, then recheck at week 4-6 and week 10-12.

Cost vs daily peptides: CJC-1295 with DAC is more expensive per vial than CJC-1295 without DAC, but because you pin less frequently, the total cost over a cycle is similar or slightly less.

Tropical climate storage: CJC-1295 with DAC should be refrigerated (2-8°C) after reconstitution. In PH, brownouts can compromise refrigeration. Unreconstituted powder is more stable.

Filipino body type and recomposition: The skinny-fat phenotype (low muscle mass, high visceral fat) is common in PH. CJC-1295 with DAC supports slow recomposition by improving muscle retention and fat oxidation.

Common stacks

CJC-1295 with DAC + Ipamorelin: The most common GH stack. CJC (GHRH pathway) + Ipamorelin (GHRP pathway) create a synergistic GH pulse. However, most users stack Ipamorelin with CJC-1295 without DAC for better pulse timing. Stacking with DAC version is less common but still effective.

CJC-1295 with DAC + BPC-157 + TB-500: For comprehensive recovery. The healing peptides address specific injuries while CJC supports systemic recovery and sleep.

CJC-1295 with DAC + Tesamorelin: For targeted visceral fat reduction. Both work through GH pathways. Protocol: 100mcg CJC 1-2x weekly + 1-2mg tesamorelin daily.

CJC-1295 with DAC + Retatrutide or Semaglutide: For muscle preservation during GLP-1-driven weight loss. CJC helps maintain lean mass while the GLP-1 drives fat loss.

Avoid stacking with exogenous GH unless under medical supervision. Combining CJC-1295 with synthetic GH creates excessive and poorly controlled GH levels.

Things to watch

Bloodwork baseline (before starting):

• IGF-1
• Fasting glucose, HbA1c
• Thyroid panel (TSH, free T3, free T4)
• Lipid panel

Week 4-6 recheck:

• IGF-1 (should be elevated but not >400-500 ng/mL)
• Fasting glucose (watch for insulin resistance)

Week 10-12:

• IGF-1 (ensure it hasnt climbed excessively)
• Fasting glucose, HbA1c

Subjective metrics:

• Sleep quality (depth, restfulness, wake-up feeling)
• Recovery between training sessions
• Body composition (waist circumference, mirror check)
• Strength and performance in the gym

Red flags:

• IGF-1 >500 ng/mL (reduce dose or stop)
• Fasting glucose increasing significantly (potential insulin resistance)
• Persistent numbness/tingling in hands (reduce dose)
• New lumps or growths (stop and get medical evaluation)

PH labs offer IGF-1 testing for 1500-2500 PHP. Comprehensive metabolic panels are 2000-4000 PHP.

Coming off / cycling

CJC-1295 with DAC does not require a taper. You can stop cold after completing your cycle.

Timeline after last pin:

• Week 1-2: GH and IGF-1 remain elevated due to 8-day half-life
• Week 3-4: Levels return to baseline
• Sleep quality and recovery may dip slightly as GH returns to pre-cycle levels

Cycling approach: Most users run CJC-1295 with DAC for 8-12 weeks, then cycle off for 4-8 weeks to allow the pituitary to normalize and prevent receptor desensitization.

Some users run it seasonally (e.g., 12 weeks twice a year during training peaks or fat loss phases).

Re-running: CJC-1295 with DAC can be cycled multiple times throughout the year. There's no evidence of tolerance with proper cycling.

Long-term use: Continuous use beyond 12-16 weeks without a break is not recommended. The pituitary may downregulate GHRH receptors, reducing effectiveness.

---

Related compounds

• CJC-1295 without DAC — Short-acting version for pulsatile GH release, more commonly stacked with Ipamorelin
• Ipamorelin — GHRP for GH release, often stacked with CJC-1295
• Tesamorelin — GHRH analog targeting visceral fat

Further reading

• Beginner guide to growth hormone peptides — Overview of CJC-1295, Ipamorelin, and GH pathways
• Sourcing framework — How to verify peptide purity
• Bloodwork guide — What to test and when

Sources

• Teichman 2006 — Pharmacokinetics of CJC-1295 with DAC, sustained GH and IGF-1 elevation
• Ionescu 2006 — Prolonged stimulation of GH secretion by CJC-1295
• Jetté 2005 — GHRH analog effects on body composition and GH pulsatility
• Bowers 2004 — GH secretagogues and clinical applications

---

Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.